# XenoTherapeutics Corp — Form D

XenoTherapeutics Corp of Enfield, NH, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-06. The offering totals $8.0M, of which $1.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-04-06
- Form: D
- Accession: 0001774010-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $1.3M
- Remaining: $6.7M
- Minimum investment: $25K
- Investors: 8
- Date of first sale: 2021-03-30
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-394752

## Issuer

- Name: XenoTherapeutics Corp
- CIK: 0001774010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3 Sunset Walk, Enfield, NH, 03748
- Phone: 2072630226

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Jon Adkins | Director | Londonderry, NH |
| Paul Holzer | Director | Enfield, NH |
| Krysta Moulton | Director | Arlington, VA |
| Jon Adkins | Executive Officer | Londonderry, NH |
| Paul Holzer | Executive Officer | Enfield, NH |
| Krysta Moulton | Executive Officer | Arlington, VA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-06-25](https://search.stillhousedata.com/formd/0001774010-19-000002) | D/A | $4.0M | $700K |
| [2019-05-21](https://search.stillhousedata.com/formd/0001774010-19-000001) | D | $4.0M | — |

## More

- [CIK 1774010 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1774010&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001774010-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.